The Menstrual Cramps Treatment Market Growth is Accelerated by Increased Adoption of Alternative Treatments

Menstrual cramps are painful spasms occurring in the lower abdomen due to the contractions of the uterus during menstruation. Traditional treatments available for menstrual cramps include over-the-counter pain medicines such as ibuprofen and naproxen. However, there has been an increased demand for alternative treatment options such as yoga, meditation, acupuncture, massage, and transcutaneous electrical nerve stimulation (TENS) therapy due to their minimal side effects.

The global Menstrual Cramps Treatment Market is estimated to be valued at US$ 652.3 Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The rising adoption of alternative treatments for menstrual cramps is one of the major key trends being witnessed in the menstrual cramps treatment market. These alternative treatments are significantly gaining popularity as they involve non-invasive procedures without any side effects. For instance, acupuncture therapy is found effective in reducing menstrual cramps by more than 50% and is preferred by many women over conventional pain medicines. Similarly, therapies like yoga, massage, and meditation help in relaxing the muscles of the uterus and lowering stress levels to get relief from menstrual pain. Furthermore, TENS therapy involves using electric pulses to block pain signals in the nerves and provides pain relief. Thus, the increasing awareness about various alternative treatment options and their effectiveness is expected to boost the growth of the menstrual cramps treatment market during the forecast period.

Segment Analysis
The global menstrual cramps treatment market can be segmented based on type into nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal contraceptives, heating pads, and others. NSAIDs dominates the global menstrual cramps treatment market as they are inexpensive and easily accessible over-the-counter drugs that provide quick relief from menstrual pain and cramps.

Key Takeaways

The global menstrual cramps treatment market is expected to witness high growth.

Regional analysis: The Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. This is attributed to the rapidly growing women population, rising awareness about menstrual hygiene, increasing disposable income, and improving healthcare infrastructure in emerging Asian countries such as China and India. Furthermore, growing awareness about menstrual pain management and availability of diverse treatment options in Asia Pacific is positively influencing the regional market.

Key players: Key players operating in the menstrual cramps treatment market are Stryker Corporation, SATELEC (Actongroup), Surgiform Innovative Surgical Products, Allergan (Abbvie), Luminera, Implantech, Koken, ANTHONY PRODUCTS INC., NOUVAG, Sihuan Pharmaceutical Holdings Group Ltd., and Other. Stryker Corporation and Allergan (Abbvie) are the leading players in the global market owing to their diversified product portfolio and strong global presence across regions.

Comments

Popular posts from this blog

Neuroendocrine Cancer is the fastest growing segment fueling the growth of Pituitary Cancer Market

Enhancing Patient Care and Comfort: The Evolution of Hospital Beds

Dry Eye Disease Market is Estimated to Witness High Growth Owing to Rising Awareness About Disease Management